Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Medical Oncology × Control Groups × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 36 Neoplasms 21 Motor Activity 11 Colorectal Neoplasms 9 Lung Neoplasms 7 Fatigue 7 Stomach Neoplasms 6 Pain, Postoperative 6 Anxiety Disorders 6 Pain 5 Polycystic Ovary Syndrome 4 Depression 4 Colonic Neoplasms 4 Carcinoma, Hepatocellular 4 Thyroid Neoplasms 3 Stomatitis 3 Sleep Initiation and Maintenance Disorders 3 Ovarian Neoplasms 3 Malnutrition 3 Leukemia, Myeloid, Acute 3 Agnosia 3 Vomiting 2 Uterine Cervical Neoplasms 2 Squamous Cell Carcinoma of Head and Neck 2 Rectal Neoplasms 2 Prostatic Neoplasms 2 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Peritoneal Neoplasms 2 Parasomnias 2 Nausea 2

Interventions

Itraconazole 2 roniciclib 1 aprutumab ixadotin 1 anetumab ravtansine 1 Diet 1 Control Groups 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02645357 2017-02-09

ONCO-CODES

Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS

Phase NA Completed

15,431 enrolled

Medical Oncology

Data powered by HemOnc (CC BY 4.0) Colophon ⚡